DHRS2 mediates cell growth inhibition induced by Trichothecin in nasopharyngeal carcinoma

[1]  A. Bode,et al.  Posttranslational regulation of PGC‐1α and its implication in cancer metabolism , 2019, International journal of cancer.

[2]  M. Skowron,et al.  Deciphering the molecular effects of romidepsin on germ cell tumours: DHRS2 is involved in cell cycle arrest but not apoptosis or induction of romidepsin effectors , 2018, Journal of cellular and molecular medicine.

[3]  Xiangjian Luo,et al.  The implications of signaling lipids in cancer metastasis , 2018, Experimental & Molecular Medicine.

[4]  Xiang-Hua Wang,et al.  Novel natural compounds from endophytic fungi with anticancer activity. , 2018, European journal of medicinal chemistry.

[5]  A. Bode,et al.  Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer , 2018, Theranostics.

[6]  Yang Han,et al.  HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5‐FU resistance by a p53‐dependent pathway , 2018, Molecular carcinogenesis.

[7]  A. Bode,et al.  DNMT1 mediates metabolic reprogramming induced by Epstein–Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma , 2018, Cell Death & Disease.

[8]  A. Nakai,et al.  Acute HSF1 depletion induces cellular senescence through the MDM2-p53-p21 pathway in human diploid fibroblasts , 2018, Journal of Cell Science.

[9]  J. Onuchic,et al.  Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy , 2018, Theranostics.

[10]  A. Čumová,et al.  Natural compounds and combination therapy in colorectal cancer treatment. , 2018, European journal of medicinal chemistry.

[11]  X. Ban,et al.  DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma , 2017, Oncogene.

[12]  Xiangjian Luo,et al.  Emerging roles of lipid metabolism in cancer metastasis , 2017, Molecular Cancer.

[13]  D. Adelson,et al.  Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action , 2017, International journal of molecular sciences.

[14]  Simion I. Chiosea,et al.  Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations , 2017, Nature Communications.

[15]  D. Herr,et al.  Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2 , 2016, Scientific Reports.

[16]  Liming Jin,et al.  Potential Pharmacological Resources: Natural Bioactive Compounds from Marine-Derived Fungi , 2016, Marine drugs.

[17]  Edwin P Hui,et al.  Nasopharyngeal carcinoma , 2016, The Lancet.

[18]  D. Newman,et al.  Natural Products as Sources of New Drugs from 1981 to 2014. , 2016, Journal of natural products.

[19]  J. Medema,et al.  Betulinic acid induces a novel cell death pathway that depends on cardiolipin modification , 2016, Oncogene.

[20]  S. Beloribi-Djefaflia,et al.  Lipid metabolic reprogramming in cancer cells , 2016, Oncogenesis.

[21]  M. Jia,et al.  Endophytic fungi with antitumor activities: Their occurrence and anticancer compounds , 2014, Critical reviews in microbiology.

[22]  Fei-Fei Liu,et al.  Nasopharyngeal Cancer: Molecular Landscape. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Xiangjian Luo,et al.  The role of targeting kinase activity by natural products in cancer chemoprevention and chemotherapy (Review). , 2015, Oncology reports.

[24]  Lunzhao Yi,et al.  A metabolic discrimination model for nasopharyngeal carcinoma and its potential role in the therapeutic evaluation of radiotherapy , 2013, Metabolomics.

[25]  Robert V Farese,et al.  Cellular fatty acid metabolism and cancer. , 2013, Cell metabolism.

[26]  Jochen Gaedcke,et al.  Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer , 2013, Clinical Cancer Research.

[27]  Yan Li,et al.  Trichothecin Induces Cell Death in NF-κB Constitutively Activated Human Cancer Cells via Inhibition of IKKβ Phosphorylation , 2013, PloS one.

[28]  S. Akman,et al.  Fatty Acid Metabolites in Rapidly Proliferating Breast Cancer , 2013, PloS one.

[29]  S. Fischer,et al.  Changes in Cancer Cell Metabolism Revealed by Direct Sample Analysis with MALDI Mass Spectrometry , 2013, PloS one.

[30]  A. Harris,et al.  How cancer metabolism is tuned for proliferation and vulnerable to disruption , 2012, Nature.

[31]  J. Dumont,et al.  Metabolic reprogramming of the tumor , 2012, Oncogene.

[32]  Claudio R. Santos,et al.  Lipid metabolism in cancer , 2012, The FEBS journal.

[33]  K. To,et al.  Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. , 2012, Seminars in cancer biology.

[34]  R. Deberardinis,et al.  Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? , 2012, Cell.

[35]  David J Newman,et al.  Natural products as sources of new drugs over the 30 years from 1981 to 2010. , 2012, Journal of natural products.

[36]  R. Tan,et al.  Trichothecin induces apoptosis of HepG2 cells via caspase-9 mediated activation of the mitochondrial death pathway. , 2012, Toxicon : official journal of the International Society on Toxinology.

[37]  A. Conesa,et al.  Differential expression in RNA-seq: a matter of depth. , 2011, Genome research.

[38]  Guohong Li,et al.  Endophytic fungus Trichothecium roseum LZ93 antagonizing pathogenic fungi in vitro and its secondary metabolites , 2010, The Journal of Microbiology.

[39]  S. Pyne,et al.  Sphingosine 1-phosphate and cancer , 2010, Nature Reviews Cancer.

[40]  A. Thorner,et al.  Mitochondrial HEP27 Is a c-Myb Target Gene That Inhibits Mdm2 and Stabilizes p53 , 2010, Molecular and Cellular Biology.

[41]  B. Persson,et al.  Medium- and short-chain dehydrogenase/reductase gene and protein families , 2008, Cellular and Molecular Life Sciences.

[42]  Yoshihiro Yamanishi,et al.  KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..

[43]  E. Maser,et al.  Carbonyl Reductases and Pluripotent Hydroxysteroid Dehydrogenases of the Short-chain Dehydrogenase/reductase Superfamily , 2007, Drug metabolism reviews.

[44]  Lin Fang,et al.  WEGO: a web tool for plotting GO annotations , 2006, Nucleic Acids Res..

[45]  H. Jörnvall,et al.  Hep27, a member of the short-chain dehydrogenase/reductase family, is an NADPH-dependent dicarbonyl reductase expressed in vascular endothelial tissue , 2006, Cellular and Molecular Life Sciences CMLS.

[46]  K. Ansari,et al.  Effects of trichothecene mycotoxins on eukaryotic cells: A review , 2005, Food additives and contaminants.

[47]  J. Ko,et al.  Monochromosome transfer provides functional evidence for growth‐suppressive genes on chromosome 14 in nasopharyngeal carcinoma , 2003, Genes, chromosomes & cancer.

[48]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[49]  S. Petersen,et al.  Chromosomal imbalances of primary and metastatic lung adenocarcinomas , 2002, The Journal of pathology.

[50]  P. D. Dal Cin,et al.  Molecular cytogenetic definition of three distinct chromosome arm 14q deletion intervals in gastrointestinal stromal tumors , 2001, Genes, chromosomes & cancer.

[51]  J. Kere,et al.  Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis , 1999, British Journal of Cancer.

[52]  A. Heguy,et al.  A nuclear protein, synthesized in growth-arrested human hepatoblastoma cells, is a novel member of the short-chain alcohol dehydrogenase family. , 1995, European journal of biochemistry.

[53]  M Krook,et al.  Short-chain dehydrogenases/reductases (SDR). , 1995, Biochemistry.

[54]  Pelayo Vilar,et al.  Nasopharyngeal Carcinoma , 1966 .